Clinical Trial Update: Study Evaluating the Safety and Efficacy of Intravenous Tigecycline to Treat Hospitalized Japanese Subjects [Phase 3]

View source ↗

Summary

Phase 3 study evaluating intravenous tigecycline for safety and efficacy in hospitalized Japanese patients with community-acquired infection has completed; resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Infection

Drugs mentioned

• Tigecycline (tigecycline)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Community-Acquired Infections | Phase 3 | Status: COMPLETED | Results posted: 2009-05-27